647 Evaluation of efficacy and toxicity of CD137 immunotherapy with urelumab-mIgG1 chimeric antibody in CD137 HuGEMM™

• Daniel He,
• Mingkun Zhang,
• Xinhe Feng,
• Annie An,
• Cunxiang Ju,
• Davy Ouyang

Affiliations

Daniel He

1Crown Bioscience Inc., San Diego, CA, USA

Mingkun Zhang

2GemPharmatech Co., Ltd, Nanjing, China

Xinhe Feng

1Crown Bioscience Inc., San Diego, CA, USA

Annie An

1Crown Bioscience Inc., San Diego, CA, USA

Cunxiang Ju

2GemPharmatech Co., Ltd, Nanjing, China

Davy Ouyang

1Crown Bioscience Inc., San Diego, CA, USA